This episode is about how small biotechs should manage CROs and vendors more strategically. Niharika’s main point is that outsourcing is not hands off. Sponsors still need strong oversight, better budget transparency, and clear goals with vendors. She also says AI can improve things like site selection, reporting, and monitoring support, but it cannot replace human judgment in clinical operations.